|
| |
Articles
1-93 out of 93 article(s)
| Title |
Author |
Type |
Date |
Words |
| Concert Pharmaceuticals Initiates Phase 1b Clinical Trial of CTP-518, Protease Inhibitor for Treatment of HIV. |
|
|
Nov 9, 2009 |
740 |
| Avila Presents Data on Its Novel, Orally-Available Protease Inhibitor, AVL-181, Demonstrating Viral Clearance of Hepatitis C Virus in Preclinical Models. |
|
|
Nov 2, 2009 |
713 |
| HIV, atherosclerosis and inflammation: implications for treatment. |
Chan, William; Sviridov, Dmitri; Dart, Anthony M. |
Report |
Nov 1, 2009 |
6415 |
| Immune activation and the pathogenesis of HIV disease: implications for therapy. |
Fernandez, Sonia; Lim, Andrew; French, Martyn |
Report |
Nov 1, 2009 |
4580 |
| Avila Presents Preclinical Data on its Novel, Orally-Available, Pan-Genotype Protease Inhibitor, AVL-181, Demonstrating Protein Silencing of Hepatitis C Virus. |
|
|
Oct 5, 2009 |
671 |
| Vertex Pharmaceuticals to Receive $155 Million in Cash Related to Future Telaprevir Milestone Payments. |
|
|
Sep 30, 2009 |
743 |
| Vertex Pharmaceuticals Announces Publication of Telaprevir Abstracts for Presentation at the 60th AASLD Meeting. |
|
|
Sep 24, 2009 |
1054 |
| Missing protein in rare genetic brain disorder restored. |
|
|
Sep 7, 2009 |
445 |
| Vertex Pharmaceuticals and Mitsubishi Tanabe Pharma Corporation Amend Agreement to Develop and Commercialize Telaprevir in Asia. |
|
|
Jul 30, 2009 |
1179 |
| Vertex Pharmaceuticals Announces Intention to Sell Its Rights to European Milestone Payments for Telaprevir. |
|
|
Jul 10, 2009 |
560 |
| Here's how Hepatitis C treatment can be significantly improved. |
|
|
Jun 6, 2009 |
424 |
| Concert Pharmaceuticals and GlaxoSmithKline Form Alliance to Develop Novel Deuterium Modified Drugs. |
|
|
Jun 2, 2009 |
825 |
| Avila Presents Preclinical Data on a Novel, Orally-Available, Protease Inhibitor, AVL181, for Hepatitis C Infection at EASL 2009 Meeting. |
|
|
Apr 27, 2009 |
844 |
| Vertex Pharmaceuticals to Present Data at EASL Suggesting Telaprevir's Potential for Use in a Broad Range of HCV Patients and Highlighting the Company's Expanded STAT-C Portfolio. |
|
|
Apr 21, 2009 |
1787 |
| Vertex Pharmaceuticals Strengthens HCV Drug Development Portfolio, Adds Novel Polymerase Inhibitors to Shape New Combinations with Telaprevir. |
|
|
Mar 3, 2009 |
2012 |
| Research and Markets: Hepatitis C Market Forecast to Grow to $4.5 Billion by 2017 as High Unmet Need Drives Rapid Innovation and Sales. |
|
Industry overview |
Feb 9, 2009 |
407 |
| New Clinical Data Support Broad Profile for Telaprevir in Patients with Genotype 1 Hepatitis C Virus (HCV) Infection. |
|
Clinical report |
Nov 1, 2008 |
2159 |
| AHF'S AIDS Drug-Pricing Campaign Arrives in Abbott Executives' Home Mailboxes. |
|
|
Oct 29, 2008 |
622 |
| Phenomix Initiates Phase 1a Clinical Trial of Hepatitis C Protease Inhibitor PHX1766. |
|
|
Oct 28, 2008 |
372 |
| AHF Steps Up "Shame on Abbott" Advocacy Campaign in Abbott Park, IL. |
|
|
Oct 6, 2008 |
594 |
| Arriva Pharmaceuticals Granted Protein Production Patent. |
|
|
Oct 1, 2008 |
541 |
| Medivir: Phase IIa data on TMC435350 in patients with hepatitis C to be presented at AASLD. |
|
|
Sep 24, 2008 |
740 |
| 'Shame on Abbott': AIDS Healthcare Foundation's New Ad Campaign Blasts Drug Company for Exploiting NAFTA to Charge Five Times More for Its Key AIDS Drug Kaletra in Mexico Than in Other Middle-Income Countries. |
|
|
Sep 16, 2008 |
660 |
| Vertex Pharmaceuticals to Start Phase 3 'REALIZE' Trial with Telaprevir in Treatment-Failure HCV Patients. |
|
|
Aug 19, 2008 |
1252 |
| CASTLE Data Showed Boosted REYATAZ(R) (atazanavir sulfate) and Lopinavir/r Achieved Similar Results for Undetectable Viral Load in Treatment-Naive HIV-1 Infected Patients, Regardless of Gender. |
|
|
Aug 6, 2008 |
1158 |
| Vertex Pharmaceuticals Sells HIV Product Royalty Stream for $160 Million. |
|
|
Jun 3, 2008 |
486 |
| New protease inhibitors and non-nucleoside reverse transcriptase inhibitors. |
Lascar, Monica; Cartledge, Jonathan D. |
Drug overview |
Jun 1, 2008 |
3759 |
| Quick-Med Technologies to Participate in Third Congress of the World Union of Wound Healing Societies in Toronto. |
|
|
May 21, 2008 |
511 |
| Arriva Pharmaceuticals Granted Fusion Protein Patent. |
|
|
May 21, 2008 |
554 |
| Europe: Boehringer Ingelheim wins European approval for HIV drug Aptivus. |
|
|
May 7, 2008 |
118 |
| The current role of ritonavir-boosted protease inhibitors in the management of HIV infection. |
Wilkins, Ed |
Report |
Mar 1, 2008 |
7693 |
| Vertex Pharmaceuticals Announces Webcast of its Presentation at the Susquehanna Financial Group's Second Annual SIGnificant Options in Healthcare Conference. |
|
Conference news |
Feb 29, 2008 |
190 |
| Final Gemini Study Results Confirm Boosted Invirase Was as Effective as Kaletra While Providing an Improved Triglyceride Profile for HIV Patients. |
|
|
Oct 25, 2007 |
1519 |
| UPDATE: FDA Approves ISENTRESS(TM) (raltegravir) Tablets, First-in-Class Oral HIV-1 Integrase Inhibitor. |
|
|
Oct 15, 2007 |
9780 |
| UPDATE: FDA Approves ISENTRESS(TM) (raltegravir) Tablets, First-in-Class Oral HIV-1 Integrase Inhibitor. |
|
|
Oct 12, 2007 |
9768 |
| Chronic wounds, molecular pathogenesis and active therapies. |
Trotter, Patrick |
|
Sep 1, 2007 |
3535 |
| Efficacy and safety of darunavir-ritonovir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials. |
Chan, Derek J. |
|
Jun 1, 2007 |
416 |
| Non-nucleoside reverse transcriptase inhibitor (NNRTI) HIV treatment regimens are better at suppressing the virus than protease inhibitor (PI) regimens. |
|
Brief article |
Jan 1, 2007 |
148 |
| Have Meds, Will Travel Traveling with meds has always been a challenge for HIVers, but things got a bit easier in October when the FDA approved a tablet form of the protease inhibitor Kaletra, making one of the world's most commonly prescribed protease inhibitors travel-ready. |
|
Brief Article |
Jan 17, 2006 |
97 |
| HIV protease inhibitors vs. malaria. |
James, John S. |
Brief Article |
Jun 24, 2005 |
122 |
| Tipranavir (Aptivus): approval cautiously recommended. |
James, John S. |
|
May 27, 2005 |
1145 |
| Good news: the effects of HAART. |
|
Brief Article |
Apr 1, 2005 |
185 |
| TMC 114. |
|
Brief Article |
Apr 1, 2005 |
84 |
| Tipranavir. |
|
|
Apr 1, 2005 |
91 |
| Erythromycin risks. |
|
Brief Article |
Apr 1, 2005 |
198 |
| Drugs for GI upset may interact with HIV protease inhibitors. |
|
Brief Article |
Apr 1, 2005 |
214 |
| Reyataz heart risks. |
|
Brief Article |
Apr 1, 2005 |
60 |
| Fewer pills for Invirase. |
|
Brief Article |
Apr 1, 2005 |
57 |
| Kaletra warning. |
|
Advertisement |
Apr 1, 2005 |
296 |
| New protease inhibitor looks promising. |
|
Brief Article |
Mar 26, 2005 |
145 |
| Triple PI therapy for salvage. |
|
Brief Article |
Oct 1, 2004 |
165 |
| Reyataz update. |
|
Brief Article |
Oct 1, 2004 |
153 |
| Fewer pills for Viracept. |
|
Brief Article |
Oct 1, 2004 |
63 |
| The hepatitis C drug development pipeline. |
Raymond, Daniel |
|
Sep 22, 2004 |
2442 |
| New protease inhibitor being studied. |
|
Brief Article |
Jun 1, 2004 |
132 |
| FDA approves HIV drug. |
|
Brief Article |
Jun 1, 2004 |
114 |
| Drug disables enzyme from hepatitis C virus. |
Travis, J |
|
Nov 1, 2003 |
456 |
| Lexiva[TM] (Fosamprenavir) approved. |
|
Brief Article |
Oct 31, 2003 |
197 |
| New protease inhibitor atazanavir (Reyataz[TM]) approved. |
|
|
Jun 27, 2003 |
436 |
| Atazanavir background documents available. |
|
Brief Article |
May 30, 2003 |
193 |
| Atazanavir expanded access. (Treatment News). |
|
Brief Article |
May 1, 2003 |
93 |
| Success of experimental AIDS drugs offers promise of future therapies. (Full pipeline). |
Seppa, N. |
|
Feb 22, 2003 |
512 |
| HIV therapies may carry health risks. |
Zipes, Douglas |
|
Feb 1, 2003 |
320 |
| Another cardiovascular risk with protease inhibitors? (Treatment News). |
|
Brief Article |
Sep 1, 2002 |
190 |
| Protease inhibitor combination therapy and decreased condom use among gay men. |
Vermund, Sten H. |
|
Apr 1, 2002 |
3791 |
| Analysis of Amino Acid and Protein Insecticides for Transgenic Crops. (Botany & Plant Ecology). |
|
Brief Article |
Mar 22, 2002 |
203 |
| Viral load: small change by sixth day of treatment can often predict poor response. |
James, John S. |
|
Nov 23, 2001 |
469 |
| Protease inhibitors in children: combination therapy reduced death by two thirds. |
James, John S. |
|
Nov 23, 2001 |
573 |
| 3-Dimensional receives patent protection. |
|
Brief Article |
Sep 1, 2001 |
262 |
| Liver Fibrosis in HIV/Hepatitis C Coinfection: HIV Protease Inhibitors May Be Protective. |
James, John S. |
|
Aug 24, 2001 |
364 |
| NEWS BRIEFS. |
|
|
Dec 1, 2000 |
1489 |
| Has Anti-HIV Treatment Cut AIDS Deaths? |
|
|
Nov 3, 2000 |
980 |
| Protease inhibitors: opium of the masses? |
Martinez, L. Joel |
|
Sep 1, 2000 |
2987 |
| HIV drugs put patients at risk for diabetes. |
|
Brief Article |
Aug 1, 2000 |
89 |
| December 24, 1996: Hope's reward. |
Romesburg, Don |
Brief Article |
May 23, 2000 |
219 |
| About the Drug Fact Sheets. |
|
|
Mar 1, 2000 |
363 |
| AIDS drugs may cause bone loss. |
D.C. |
Brief Article |
Feb 12, 2000 |
236 |
| Mixed blessings. |
Zingale, Daniel |
|
Jul 21, 1998 |
1834 |
| The good news: protease inhibitors. |
Seppa, Nathan |
Brief Article |
Feb 28, 1998 |
310 |
| The bad news: protease inhibitors. |
Seppa, Nathan |
Brief Article |
Feb 28, 1998 |
189 |
| AIDS service organizations face ethical challenges. |
|
|
Feb 1, 1998 |
992 |
| Study shows 50% failure for protease inhibitors. |
Pallatroni, Lisa |
|
Nov 1, 1997 |
342 |
| Financial inhibitors. |
Gallagher, John |
|
Sep 16, 1997 |
638 |
| Protease inhibitors turn 1. |
Gallagher, John |
|
Sep 2, 1997 |
1226 |
| Protease inhibitors may cause diabetes, FDA warns. |
|
|
Aug 1, 1997 |
467 |
| AIDS / Drug Study. |
|
|
Jul 31, 1997 |
674 |
| The new crisis facing AIDS organizations: adapt or die. |
Gallagher, John |
|
May 27, 1997 |
1923 |
| More signs that hospices must clarify role in HIV. |
|
|
Mar 1, 1997 |
1510 |
| Protease inhibitor shows promise with HIV patients. |
|
|
Feb 1, 1997 |
128 |
| Life-saving AIDS therapy forcing hospice to reconsider its mission. |
|
|
Jan 1, 1997 |
1725 |
| Federal and state funding for drugs pushed to limit. |
|
|
Jan 1, 1997 |
667 |
| AIDS optimism high despite therapy cost. |
Sternberg, Steve |
|
Jul 13, 1996 |
640 |
| Epilepsy gene identified. |
|
Brief Article |
Apr 6, 1996 |
266 |
|
